NCT06275061 Chinese Obesity and MEtabolic Surgery Database (COMES Database)
| NCT ID | NCT06275061 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Jinan University Guangzhou |
| Condition | Obesity |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000,000 participants |
| Start Date | 2020-05-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000,000 participants in total. It began in 2020-05-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the Chinese Obesity and MEtabolic Surgery Database (COMES Database) is to collect data and examine the long-term effects of metabolic and bariatric surgery on obesity and metabolic disorders in the Chinese population.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed as obesity undergoing metabolic and bariatric surgery. Exclusion Criteria: * Patients treated by non-surgical modalities.
Contact & Investigator
Cunchuan Wang, MD, PhD
STUDY CHAIR
First Affiliated Hospital of Jinan University
Frequently Asked Questions
Who can join the NCT06275061 clinical trial?
This trial is open to participants of all sexes, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06275061 currently recruiting?
Yes, NCT06275061 is actively recruiting participants. Contact the research team at yangwah@qq.com for enrollment information.
Where is the NCT06275061 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT06275061 clinical trial?
NCT06275061 is sponsored by Jinan University Guangzhou. The principal investigator is Cunchuan Wang, MD, PhD at First Affiliated Hospital of Jinan University. The trial plans to enroll 1,000,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.